Uricase Therapy

Uricase Therapy is a therapeutic enzyme treatment that catalyzes the oxidation of uric acid into the more soluble compound allantoin, thereby reducing serum urate levels in patients with refractory gout or hyperuricemia.

79

Publications

5.2K

Citations

444

Authors

145

Institutions

Publications per year

2017–2026

31

Authors

444

  1. RT
    Robert Terkeltaub

    University of California San Diego, United States

    6 publications · 319 citations

    6

    h-index

  2. PE
    Peter E. Lipsky

    The University of Texas Southwestern Medical Center, United States

    5 publications · 891 citations

    5

    h-index

  3. JS
    John S. Sundy

    Duke Medical Center, United States

    5 publications · 1.5K citations

    5

    h-index

  4. HS
    Herbert S. B. Baraf

    Center for Rheumatology, United States

    4 publications · 743 citations

    4

    h-index

  5. AK
    Alan Kivitz

    Altoona Center for Clinical Research, United States

    4 publications · 112 citations

    4

    h-index

1–5 of 444

Venues

  1. PubMed

    Repository · 5 publications · 165 citations

    5

    h-index

  2. Annals of the Rheumatic Diseases

    ARD · 3 publications · 56 citations

    3

    h-index

  3. PLoS ONE

    3 publications · 129 citations

    3

    h-index

  4. Rheumatology and Therapy

    3 publications · 69 citations

    3

    h-index

  5. Arthritis Research & Therapy

    3 publications · 653 citations

    3

    h-index

1–5